Clinical Characteristics of the Three Groups Based on ICGR15 and Pathologically Proven LC
Table 1 shows the clinical characteristics of the 479 patients included in our cohort, divided into three groups. The Chi-squared and Kruskal-Wallis tests revealed significant intergroup differences in BMI (kg/m2, P = 0.040), albumin (g/dL, P < 0.001), ALT (IU/L, P = 0.016), AST (IU/L, P < 0.001), ICGR15 value (%, P < 0.001), esophageal varix (no/yes, P < 0.001), platelet count (x104/mm3, P < 0.001), PT% (%, P < 0.001), Child-Pugh classification (A/B, P < 0.001), HBs antigen (negative/positive, P < 0.001), HCV antibody (negative/positive, P < 0.001), APRI (P < 0.001), FIB-4 index (P < 0.001), hyaluronic acid (ng/mL, P < 0.001), type IV collagen 7S domain (ng/mL, P < 0.001), performance of anatomical resection (yes/no, P < 0.001) and major hepatectomy (yes/no, P < 0.001), operative complication (Clavien-Dindo grade 0-II/III-V, P = 0.011), tumor-node-metastasis (TNM) stage (I, II/III, IV, P < 0.001), postoperative hospital stay (day, P < 0.001), and degree of liver fibrosis (0–1/2–3/4, P < 0.001) .
Table 1
The clinical characteristics of three groups (A, B and C) divided by ICGR15 and pathologically proven liver cirrhosis
Variable
|
Group A
(n = 112)
|
Group B
(n = 71)
|
Group C
(n = 296)
|
P-value
|
Age (yr)
|
68 (61–74)
|
67 (58–71)
|
66 (60–72)
|
0.605
|
Gender (male/female)
|
86/26
|
57/14
|
217/79
|
0.428
|
BMI (kg/m2)
|
22.6 (20.6–24.7)
|
22.2 (19.7–25.1)
|
23.2 (20.5–26.1)
|
0.040
|
Albumin (g/dL)
|
3.8 (3.4–4.1)
|
3.6 (3.4–4.0)
|
3.3 (3.0–3.7)
|
< 0.001
|
ALT (IU/L)
|
33 (23 − 47)
|
31 (21–44)
|
34 (23–49)
|
0.016
|
AST (IU/L)
|
30 (19–43)
|
32 (24–42)
|
41 (31–59)
|
< 0.001
|
ICGR15 (%)
|
7 (5–9)
|
8 (6–9)
|
21 (16–31)
|
< 0.001
|
Esophageal varix (no/yes)
|
102/10
|
48/19
|
141/151
|
< 0.001
|
Platelet count (x104/mm3)
|
18.5 (15.1–22.7)
|
12.5 (9.6–16.1)
|
10.6 (7.4–14.1)
|
< 0.001
|
PT% (%)
|
89 (81–95)
|
81 (76–89)
|
78 (70–85)
|
< 0.001
|
Total bilirubin (mg/dL)
|
0.5 (0.4–0.7)
|
0.5 (0.4–0.7)
|
0.7 (0.7–0.9)
|
0.503
|
Child-Pugh classification (A/B)
|
101/11
|
64/7
|
217/79
|
< 0.001
|
HBs antigen (negative/positive)
|
93/19
|
53/18
|
271/25
|
< 0.001
|
HCV antibody (negative/positive)
|
61/51
|
34/37
|
63/233
|
< 0.001
|
APRI
|
0.6 (0.4–0.8)
|
0.8 (0.6–1.4)
|
1.4 (0.8–2.1)
|
< 0.001
|
FIB-4 index
|
2.19 ( 1.63–2.80)
|
2.94 (2.07–4.28)
|
4.64 (3.01–6.72)
|
< 0.001
|
Hyaluronic acid (ng/mL)
|
69 (41–107)
|
108 (48 − 188)
|
237 (117 − 406)
|
< 0.001
|
Type IV collagen 7S domain (ng/mL)
|
5.1 (4.2–6.3)
|
5.9 (4.8–8.7)
|
7.5 (6.0–10.0)
|
< 0.001
|
Anatomical resection (no/yes)
|
22/90
|
18/53
|
174/122
|
< 0.001
|
Major hepatectomy (no/yes)
|
86/26
|
67/4
|
283/13
|
< 0.001
|
Operative bleeding (mL)
|
420 (210–772)
|
462 (201–789)
|
497 (254–955)
|
0.547
|
Operative complication (CD grade 0-II/III-V)
|
91/21
|
54/17
|
198/98
|
0.011
|
Operative time (min)
|
270 (220–360)
|
247 (200–337)
|
261 (205–342)
|
0.478
|
Surgery (open/laparoscopic)
|
110/2
|
67/4
|
292/4
|
0.074
|
TNM stage (I/II/III/IV)
|
41/24/45/2
|
36/21/11/3
|
67/108/90/31
|
< 0.001
|
Postoperative hospital stay (day)
|
14 (12–20)
|
19 (14–31)
|
23 (14–35)
|
< 0.001
|
Degree of liver fibrosis (0–1/2–3/4)
|
49/63/0
|
0/0/71
|
0/0/296
|
< 0.001
|
Chi-squared test, Median (IQR), Kruskal-Wallis test
AFP; alpha-fetoprotein, ALT; alanine aminotransferase,
APRI; Aspartate aminotransferase-to-platelet ratio index, AST; aspartate aminotransferase,
BMI; body mass index, CRP; C-reactive protein,
ICGR15; indocyanine green retention rate at 15 minutes,
PIVKA-II; protein induced by Vitamin K antagonist II, PT; prothrombin time,
TNM stage; Tumor-node-metastasis stage
In the comparison of clinical characteristics between the three groups, albumin, ALT, AST, total bilirubin, and Child-Pugh classification (A/B) of Group B were similar to those of Group A. On the other hand, PT% (P = 0.001), platelet count (P < 0.001), and postoperative hospital day (P = 0.001) of Group B were worse than those of Group A. In addition, these factors of Group C were significantly worse than those of Group B (PT%: P = 0.017, platelet count: P = 0.002, postoperative hospital stay: P = 0.007).
Postoperative Ascites of Patients in the Three Groups
Figure 2 shows the amount of postoperative ascites in the three groups (A, B and C). The Mann-Whitney U test revealed that the amount of ascites (mL) at postoperative day 4, day 7 and day 10 in patients of Group A was significantly smaller than that of the other two groups (Group A vs. Group B: P = 0.006 on day 4, P < 0.001 on day 7, and P < 0.001 on day 10; Group A vs. Group C: P < 0.001 on day 4, P < 0.001 on day 7, P < 0.001 on day 10).
Rate of LC and Change in Operation Plan Among Patients with ICGR15 ≤10%
Among 183 patients with ICGR15 ≤ 10% who underwent liver resection, 71 patients had pathologically proven LC. Additionally, operative plans were changed intraoperatively in 8 patients due to concerns for potential postoperative liver failure as follows: segmentectomy to partial liver resection in 4 patients, segmentectomy to subsegmentectomy in 2 patients, lobectomy to partial liver resection and subsegmentectomy to partial liver resection in one patient each. Among these 8 patients, 5 patients had postoperative complications: 2 patients developed pleural effusions, one patient developed ascites, one patient developed a bile leak, and one patient developed postoperative fevers. The median postoperative hospital day was 14 days (range 6 to 147 days).
Value of CT for Diagnosing LC in Patients with ICGR15 ≤10%
Using the available preoperative CT findings of 55 patients with both ICGR15 ≤ 10% and pathological LC, 24 patients (43.6%) were diagnosed as LC by radiologists. Among these 24 patients, 16 patients had nodular liver contour, 13 patients had splenomegaly, 10 patients had an enlarged left lobe, and 7 patients had atrophy of the right lobe.
Relationship between Enhanced MRI Imaging and Liver Volume in the Three Groups Divided by ICGR15 Value and Liver Cirrhosis
One-hundred and one patients had CT and MRI imaging available prior to surgery: 27 patients in Group A, 20 in Group B, and 54 in Group C. Figure 3 shows the relationship between enhanced MRI imaging and liver volume between the three groups. The median value of TLV in Group A, B and C was 1125 ml, 1146 ml and 1159 ml, respectively; the median value of FLV in Group A, B and C was 982 ml, 890 ml and 697 ml, respectively There was no significant difference in TLV among the three groups. FLV of Group C was significantly less than that of Group A and B (Group C vs Group A: P < 0.001, Group C vs. Group B: P = 0.006). Despite no significant difference in FLV between Groups A and B (P = 0.282), the median value of FLV in Group B was smaller than that in Group A (982 ml vs 890 ml).
Liver Parenchymal Cell Volume Ratio in the Three Groups Divided by ICGR15 Value and Liver Cirrhosis
Among the 101 patients with available MRI findings, sections of formalin-fixed paraffin-embedded non-tumor tissues were stained by hematoxylin and eosin. The median values of liver parenchymal cell volume ratio in Group A, B, and C was 88.7%, 84.3% and 79.7%, respectively. Mann-Whitney U-test showed a significant intergroup difference among the three groups (Group A vs. Group B: P = 0.002, Group A vs. Group C: P < 0.001, Group B vs. Group C, P = 006) (Fig. 4).
Uni- and Multi-variate Analyses to Detect Clinical Characteristics Correlating with LC in Patients with ICGR15 ≤10%
Table 2 shows uni- and multivariate analyses using liver fibrosis markers to identify useful predictors of LC in 183 patients with ICGR15 ≤ 10%. Univariate analysis revealed a significant association between LC and esophageal varix (yes/no), platelet count (< 12/≥12, x104/mm3), PT% (< 80/≥80, %), APRI (> 0.8/≤0.8), FIB-4 index (> 2.6/≤2.6), hyaluronic acid (> 120/≤120, ng/mL), type IV collagen 7S domain (> 6.5/≤6.5, ng/mL) and AFP (> 8/≤8,ng/mL). Using these significant characteristics for diagnosis of LC, multivariate analysis revealed that platelet count (< 12/≥12, x104/mm3) (OR, 5.012; 95% CI 1.116–13.08; P = 0.001) and PT% (< 80/≥80, %) (OR, 2.447; 95% CI 1.116–5.366; P = 0.025) were closely associated with LC. Sensitivity, specificity, and diagnostic accuracy of the combination of these two characteristics for diagnosing LC in patients with ICGR15 ≤ 10% were 69.0 %, 69.6 % and 69.3%, respectively.
Table 2
Univariate and multivariate analyses in relation to pathological liver cirrhosis among 183 patients with normal ICGR15 value (≤ 10%).
|
Univariate analyses
|
Multivariate analyses
|
Variable
|
P-value
|
OR
|
95% C.I.
|
P-value
|
OR
|
95% C.I.
|
Age (> 70/≤70, yr)
|
0.788
|
0.921
|
0.504–1.683
|
|
|
|
Gender (male/female)
|
0.577
|
1.231
|
0.593–2.556
|
|
|
|
BMI (< 22/≥22, kg/m2)
|
0.781
|
1.088
|
0.600–1.973
|
|
|
|
Albumin (< 3.7/≥3.7, g/dL)
|
0.115
|
1.620
|
0.890–2.951
|
|
|
|
ALT (> 42/≤42, IU/L)
|
0.892
|
0.955
|
0.489–1.864
|
|
|
|
AST (> 30/≤30, IU/L)
|
0.766
|
1.095
|
0.603–1.988
|
|
|
|
Esophageal varix (yes/no)
|
0.001
|
3.998
|
1.727–9.254
|
0.569
|
1.352
|
0.478–3.827
|
Platelet count (< 12/≥12, x104/mm3)
|
< 0.001
|
6.998
|
3.331–14.70
|
0.001
|
5.012
|
1.920–13.08
|
PT% (< 80/≥80, %)
|
0.006
|
2.520
|
1.301–4.879
|
0.025
|
2.447
|
1.116–5.366
|
Total bilirubin (> 0.6/≤0.6, mg/dL)
|
0.533
|
1.220
|
0.653–2.278
|
|
|
|
Child-Pugh classification (B/A)
|
0.993
|
1.004
|
0.370–2.724
|
|
|
|
HBs antigen (positive/negative)
|
0.171
|
1.662
|
0.803–3.441
|
|
|
|
HCV antibody (positive/negative)
|
0.386
|
1.302
|
0.717–2.362
|
|
|
|
APRI (> 0.8/≤0.8)
|
< 0.001
|
4.062
|
2.146–7.691
|
0.483
|
1.432
|
0.525–3.903
|
FIB-4 index (> 2.6/≤2.6)
|
< 0.001
|
3.676
|
1.966–6.874
|
0.898
|
0.934
|
0.329–2.655
|
Hyaluronic acid (> 120/≤120, ng/mL)
|
< 0.001
|
3.556
|
1.827–6.921
|
0.088
|
2.102
|
0.896–4.933
|
Type IV collagen 7S domain (> 6.5/≤6.5, ng/mL)
|
0.013
|
2.293
|
1.193–4.408
|
0.894
|
1.057
|
0.471–2.370
|
AFP (> 8/≤8, ng/mL)
|
0.010
|
2.260
|
1.220–4.184
|
0.203
|
1.633
|
0.768–3.474
|
95% C.I.; 95% confidence interval, OR; odds ratio
AFP; a-fetoprotein, ALT; alanine aminotransferase,
APRI; Aspartate aminotransferase-to-platelet ratio index, AST; aspartate aminotransferase,
BMI; body mass index, ICGR15; indocyanine green retention rate at 15 minutes,
PT; prothrombin time